Stock Details
3349.T is COSMOS Pharmaceutical Corporation's stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 19,430.59¥. Average daily volumn in 3 months 136.94k. Market cap 803.47B



Stock symbol : 3349.T. Exchange : Tokyo. Currency : JPY
Lastest price : 20,290.00¥. Total volume : 92.40k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

COSMOS Pharmaceutical Corporation (3349.T)
Last Price
20,290.00¥
Change
-120.00
Volume
92.40k

Previous Close20,410.00
Open20,500.00
Day Range20,290.00-20,700.00
Bid20,290.00 x N/A
Ask20,330.00 x N/A
Volume92.4k
Average Volume136.94k
Market Cap803.47B
Beta0.26
52 Week Range14,710.00-20,700.00
Trailing P/E27.92
Foward P/E19.94
Dividend (Yield %)0.44%
Ex-Dividend Date2021-11-29



Financial Details


According to COSMOS Pharmaceutical Corporation's financial reports the company's revenue in 2021 were 726.42B an increase( +6.14%) over the years 2020 revenue that were of 684.4B. In 2021 the company's total earnings were 27.16B while total earnings in 2020 were 21.43B( +28.57%).


Loading ...



Organization

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates an online drug store. The company was founded in 1983 and is headquartered in Fukuoka, Japan.

Market Cap:
803.47B
Revenue:
726.42B
Total Assets:
341.32B
Total Cash:
55.11B


News about "COSMOS Pharmaceutical Corporation"

UPDATE - Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuti ...

Source from : Associated Press - 1 days ago


Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company's Senior Lender, Further Enhancing the Balance Sheet

CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic ...

Source from : Benzinga.com - 1 month ago


COSMOS Pharmaceutical Corp.

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Source from : Wall Street Journal - 1 month ago


Micro Cap Pops On $5M Investment

A Chicago-based micro cap just secured a major investment from Ault Global Holdings Inc. Shares of Cosmos Holdings Inc. (OTCQX:COSM) rallied on the $5-million investment announcement. Cosmos Holdings ...

Source from : BayStreet - 1 days ago


Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021

CHICAGO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, ...

Source from : Yahoo Finance - 1 month ago


Cosmo Pharmaceuticals N.V.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Source from : Barron's - 1 month ago


COSMOS Pharmaceutical Corporation (3349.T)

S&P 500 ends slightly higher, rising for the first time in three sessions as investors eye earnings, better-than-expected jobless claims ...

Source from : Yahoo Finance - 21 days ago


iOnctura Strengthens Management With Appointment of Sean A. MacDonald as Chief Business Officer

He was CEO of Corbin Therapeutics, Head of Business Development at Cosmo Pharmaceuticals (COPN ... “The rigor which the company has applied to its pipeline has resulted in the emergence of ...

Source from : Morningstar%2c Inc. - 1 month ago


Lake Highlands pup finds his way from laboratory specimen to ball of love_image

Lake Highlands pup finds his way from laboratory specimen to ball of love

Cosmo was born to be a laboratory "specimen" for experimental studies in Memphis, Tennessee. He made his way to a family that loves him.

Source from : Oak Cliff - Advocate - 22 days ago


Health and Beauty Retailers Market

Cosmos Pharmaceutical Corp, Amazon Etc. With n-number of tables and figures examining the Health and Beauty Retailers, the research gives you a visual, one-stop breakdown of the leading products ...

Source from : openpr.com - 1 month ago


A $40.8 Billion Global Opportunity for Assisted Reproductive Technology by 2026 - New Research from StrategyR

SAN FRANCISCO, Sept. 1, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Assisted ...

Source from : Yahoo Finance - 21 days ago


Budesonide Market Report 2021: Size, Share, Key Companies, New Business Development, Opportunities, Future Growth Analysis 2027

The report also provides an in depth overview of the merchandise portfolios, company overviews, growth strategies, revenue generation, geographic presence. The Budesonide report provides up so far ...

Source from : MarketWatch - 1 month ago


Kazia Therapeutics eyeing commercialisation revenue after “game-changing” FY21

but our future success will more and more be measured in the delivery of milestones relating not to the drug’s exploration but to its commercialisation,” the company said in its colourful, ...

Source from : Proactiveinvestors - 27 days ago


Hepatic Encephalopathy Drugs Market Size, Recent Innovations, Upcoming Status, Trends, Top Brands and Advancement 2021 to 2026

1.5.2 Global Hepatic Encephalopathy Drugs Production Capacity by Geographic Region 2.1.3 Company AHepatic Encephalopathy Drugs Product and Services 2.1.4 Company AHepatic Encephalopathy Drugs ...

Source from : MarketWatch - 21 days ago


Fertility clinics reap rich payments from pharmaceutical companies

How much sponsorship is given to fertility clinics by pharmaceutical companies in ... Would you chip in to run the conference?’ “The drug company has no input into what is actually discussed ...

Source from : Cosmos - 15 days ago


Kissei Pharmaceutical Co. Ltd.

1 Day 4547 -2.38% DJIA -0.48% S&P 500 -0.91% Health Care/Life Sciences 0.31% Mutsuo Kanzawa Chairman & Chief Executive Officer Kissei Pharmaceutical Co., Ltd. Yoshio Furihata President, COO ...

Source from : Wall Street Journal - 5 days ago


Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, ...

Source from : TMCnet - 1 days ago


Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet

CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, ...

Source from : Yahoo Finance - 1 month ago


A $40.8 Billion Global Opportunity for Assisted Reproductive Technology by 2026 - New Research from StrategyR

Companies: 11 - Players covered include Bloom Fertility Centre; Cosmos Biomedical Ltd.; Cryolab Ltd.; European Sperm Bank ApS; Ferring Pharmaceuticals ... relevant to your company; 3.4 million ...

Source from : Benzinga.com - 21 days ago


Kazia Therapeutics eyeing commercialisation revenue after “game-changing” FY21

cosmos-inspired annual report. “In subtle but fundamental ways, the game has changed.” Kazia CEO Dr James Garner said the company had ended the 2021 financial year in the strongest position in ...

Source from : Proactiveinvestors UK - 26 days ago


CSMYF.PK - Cosmos Pharmaceutical Corp Profile | Reuters

COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks ...

Source from : Reuters - 4 month ago


COSMO Pharmaceuticals N.V. Registered Shares (CMOPF)

Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information. Institutional ...

Source from : Nasdaq - 1 year ago


‘Bewilderment’ explores the stars and the soul_image

‘Bewilderment’ explores the stars and the soul

A good book can take us on a journey. Perhaps it is a journey outward, into the wider world and what lies beyond. Or maybe inward, an exploration of ...

Source from : The Maine Edge - 8 hours ago


COSMO Pharmaceuticals N.V. Registered Shares (CMOPF)

Real-time Data is provided using Nasdaq Last Sale Data Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent.

Source from : Nasdaq - 1 year ago


Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation

CET Acacia Pharma Group plc (“Acacia Pharma”, the“Group” or the“Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at ...

Source from : Middle East North Africa Financial Network - 6 days ago


Insights on the Pharmacies and Healthcare Stores Global Market to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com

Medipal Holdings Toho holdings Shiseido Welcia Paltac Corporation Cosmos Pharmaceutical Co., Ltd China National Accord Medicines Corporation Pfizer Pharmaceuticals Ltd Beijing Tong Ren Tang Co ...

Source from : The Register-Herald - 1 month ago


Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021 - Seite 2

“Importantly, over the past three months I began reducing the Company’s debt and have converted $5.25 million of debt to equity, further illustrating my commitment and confidence in Cosmos ...

Source from : wallstreet online - 1 month ago


RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

The Company previously announced that it had signed collaborations with several U.S., European and Canadian suppliers, including with Cosmo Pharmaceuticals for large-scale ramp-up of opaganib ...

Source from : PR Newswire - 27 days ago


Local pharmaceutical appeal to EAC govts for protection against imported drugs

Piere Claver Niyonizigeye, the company director of administration ... Rolando Satzke, the chief executive officer of Cosmos Pharmaceutical Limited, leading manufacturers of human health medicine ...

Source from : New Vision - 2 years ago


Hepatic Encephalopathy Market in Pharmaceutical industry | estimates US$ 355.4 Mn growth during 2021-2027

Global Hepatic Encephalopathy Market, by Drug Class (Laxatives, L-aspartate, Antibiotics, L-aspartate and others), by Route of Administration (Oral, Rectal and Intravenous), by Distribution Channel ...

Source from : List of Banks in Belarus - 7 days ago


Zhaoke Ophthalmology's Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint

Topline results of the Phase III COSMO study show that its objective ... is a leading ophthalmic pharmaceutical company dedicated to the research, development, manufacturing and commercialization ...

Source from : Business Insider - 1 month ago


Free Science Fair Fest Held Online October 9

Broward County Library's Sunrise Dan Pearl Branch is hosting the online 5th Annual Science Fair Fest, offering hands-on science experiments, ideas for science fair projects and chances to win prizes, ...

Source from : Le Lézard - 5 days ago


ESM Continues Expansion: Briony Smith Joins Product Team

Briony brings 2+ years of experience in communications and social media management. She will be responsible for campaign set-up, monitoring, and optimization in all social media ad buying platforms.

Source from : Le Lézard - 5 days ago


RedHill Biopharma Ltd.: RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

The Company previously announced that it had signed collaborations with several U.S., European and Canadian suppliers, including with Cosmo Pharmaceuticals for large-scale ramp-up of opaganib ...

Source from : Finanznachrichten - 27 days ago